Matsuo Koji, Matsuzaki Shinya, Mandelbaum Rachel S, Matsushima Kazuhide, Klar Maximilian, Grubbs Brendan H, Roman Lynda D, Wright Jason D
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California.
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.
J Surg Oncol. 2020 Feb;121(2):402-409. doi: 10.1002/jso.25770. Epub 2019 Nov 19.
To examine the association between hospital surgical volume and perioperative mortality of pelvic exenteration performed for gynecologic malignancies.
A population-based retrospective study utilizing the Nationwide Inpatient Sample was conducted to examine pelvic exenteration for gynecologic malignancies from 2001 to 2011. Annualized hospital surgical volume was defined as the average number of procedures a hospital performed per year in which at least one case was performed, and this was correlated to perioperative mortality.
A total 1912 exenterations performed at 181 centers were included. Nearly two thirds of exenteration-performing centers had a minimum surgical volume of one case per year (121 centers, 66.9%). Perioperative mortality rate was 1.8%. In multivariable analysis surgical volume remained an independent factor for perioperative mortality (adjusted-odds ratio 0.21; 95% confidence interval, 0.09-0.49; P < .001). Perioperative mortality rates were 3.7% for the centers with minimum surgical volume (1 exenteration a year), 1.4% for the centers performing more than one but two or less exenterations a year, and 0% for the top decile centers (>2 exenterations a year), respectively (P < .001).
Pelvic exenteration for gynecologic malignancy is a rare surgical procedure with most hospitals performing few cases annually. A higher surgical volume of pelvic exenteration was associated with lower perioperative mortality.
探讨妇科恶性肿瘤盆腔廓清术的医院手术量与围手术期死亡率之间的关联。
利用全国住院患者样本进行一项基于人群的回顾性研究,以考察2001年至2011年期间妇科恶性肿瘤盆腔廓清术的情况。年度医院手术量定义为一家医院每年至少实施一例手术的平均手术例数,并将其与围手术期死亡率相关联。
纳入了在181个中心实施的总共1912例廓清术。近三分之二实施廓清术的中心每年的最低手术量为1例(121个中心,66.9%)。围手术期死亡率为1.8%。在多变量分析中,手术量仍然是围手术期死亡率的一个独立因素(调整比值比为0.21;95%置信区间为0.09 - 0.49;P < 0.001)。每年最低手术量(每年1例廓清术)的中心围手术期死亡率为3.7%,每年实施超过1例但2例或更少廓清术的中心为1.4%,而手术量排名前十分之一的中心(每年>2例廓清术)为0%(P < 0.001)。
妇科恶性肿瘤盆腔廓清术是一种罕见的外科手术,大多数医院每年实施的病例数很少。盆腔廓清术的手术量越高,围手术期死亡率越低。